Evaxion A/S - Sponsored ADR (EVAX) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Evaxion A/S - Sponsored ADR and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Evaxion A/S - Sponsored ADR is the larger, with a market value of $27.2M against $24.7M — 1.1× the size. Across the 8 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 6 and Evaxion A/S - Sponsored ADR on 2.

Valuation

Metric EVAX RADX Biotechnology median
P/E n/m — 7.88
P/S 2.31 — 11.47
P/B 2.59 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.63 n/m 10.73
Earnings yield (29.31%) — (28.84%)
Free cash flow yield (149.03%) 0.00% (23.03%)

Profitability

Metric EVAX RADX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (96.10%) 0.00% (57.72%)
Return on assets (36.20%) 0.00% (49.22%)
Return on invested capital (245.79%) 0.00% 0.00%

Growth

Metric EVAX RADX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 89.85% (1.97%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric EVAX RADX Biotechnology median
Debt to equity 0.71 0.00 0.00
Current ratio 5.06 1.16 4.73
Net debt to EBITDA 1.87 0.07 0.96

Dividend

Metric EVAX RADX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric EVAX RADX Biotechnology median
Market cap 27.19m 24.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack